Skip to main content
Top
Published in: Osteoporosis International 12/2005

01-12-2005 | Original Article

The aluminum content of bone increases with age, but is not higher in hip fracture cases with and without dementia compared to controls

Authors: Hans-Olov Hellström, Bengt Mjöberg, Hans Mallmin, Karl Michaëlsson

Published in: Osteoporosis International | Issue 12/2005

Login to get access

Abstract

Aluminum is considered a potentially toxic metal, and aluminum poisoning may lead to three types of disorders: aluminum-induced bone disease, microcytic anemia and encephalopathy. This is well known in patients with chronic renal failure, but since healthy subjects with normal renal function retain 4% of the aluminum consumed, they are also at risk of long-term low-grade aluminum intoxication. Included in this study were a total of 172 patients (age range 16–98 years) with the aim of examining whether aluminum accumulates in bone with increasing age. Additionally, we aimed to investigate whether the aluminum content of bone differs between controls and hip fracture cases with and without dementia, in particular in those with Alzheimer’s disease. During operations for all cases, bone biopsies were taken with an aluminum-free instrument from the trabecular bone. The samples were measured for their content of aluminum using an inductively coupled mass spectrometer. We found an exponential increase in aluminum content of bone with age. The average aluminum values, adjusted for age, were similar in men and women (P=0.46). No significant differences in sex- and age-adjusted mean aluminum values between the controls and the hip fracture cases with (P=0.72) and without (P=0.33) dementia could be detected. The average aluminum concentration among cases with Alzheimer’s disease was also similar to the values of hip fracture patients with other types of dementia (P=0.47). Odds ratios of hip fracture for each quartile of aluminum content in bone were also estimated to detect non-linear effects, but we did not find any statistically significant association remaining after age and sex adjustment. Thus, our results indicate that we accumulate aluminum in bone over our life span, but this does not seem to be of major pathogenetic significance for the occurrence of hip fracture or dementia.
Literature
2.
go back to reference Varo P, Koivistoinen P (1980) Mineral element composition of Finish foods. Acta Agric Scand 22:161–171 Varo P, Koivistoinen P (1980) Mineral element composition of Finish foods. Acta Agric Scand 22:161–171
3.
go back to reference Drüeke TB (2002) Intestinal absorption of aluminum in renal failure. Nephrol Dial Transplant 17 [Suppl 2]:13–16 Drüeke TB (2002) Intestinal absorption of aluminum in renal failure. Nephrol Dial Transplant 17 [Suppl 2]:13–16
4.
go back to reference Priest ND (1999) Aluminum. Occurrence and toxicity. In: Sadler JJ, Caballero B (eds) Encyclopedia of human nutrition. Academic Press, San Diego, pp 59–66 Priest ND (1999) Aluminum. Occurrence and toxicity. In: Sadler JJ, Caballero B (eds) Encyclopedia of human nutrition. Academic Press, San Diego, pp 59–66
5.
go back to reference Yokel RA, McNamara PJ (2001) Aluminum toxicokinetics: an updated minireview. Pharmacol Toxicol 88:159–167CrossRefPubMed Yokel RA, McNamara PJ (2001) Aluminum toxicokinetics: an updated minireview. Pharmacol Toxicol 88:159–167CrossRefPubMed
6.
go back to reference Pérez-Granados AM, Vaquero MP (2002) Silicon, aluminum, arsenic and lithium: essentiality and human health implications. J Nutr Health Aging 6:154–162PubMed Pérez-Granados AM, Vaquero MP (2002) Silicon, aluminum, arsenic and lithium: essentiality and human health implications. J Nutr Health Aging 6:154–162PubMed
7.
go back to reference Priest ND (2004) The biological behaviour and bioavailability of aluminum in man, with special reference to studies employing aluminum-26 as a tracer: review and study update. J Environ Monit 6:375–403CrossRefPubMed Priest ND (2004) The biological behaviour and bioavailability of aluminum in man, with special reference to studies employing aluminum-26 as a tracer: review and study update. J Environ Monit 6:375–403CrossRefPubMed
8.
go back to reference Moore PB, Day JP, Taylor GA, Ferrier IN, Fifield LK, Edwardson JA (2000) Absorption of aluminum-26 in Alzheimer’s disease, measured using accelerator mass spectrometry. Dement Geriatr Cognit Disord 11:66–69CrossRef Moore PB, Day JP, Taylor GA, Ferrier IN, Fifield LK, Edwardson JA (2000) Absorption of aluminum-26 in Alzheimer’s disease, measured using accelerator mass spectrometry. Dement Geriatr Cognit Disord 11:66–69CrossRef
9.
go back to reference Taylor GA, Ferrier IN, McLoughlin IJ, Fairbairn AF, McKeith IG, Lett D, Edwardson JA (1992) Gastrointestinal absorption of aluminum in Alzheimer’s disease: response to aluminum citrate. Age Ageing 21:81–90PubMed Taylor GA, Ferrier IN, McLoughlin IJ, Fairbairn AF, McKeith IG, Lett D, Edwardson JA (1992) Gastrointestinal absorption of aluminum in Alzheimer’s disease: response to aluminum citrate. Age Ageing 21:81–90PubMed
10.
go back to reference Alfrey AC (1987) Aluminum metabolism and toxicity in uremia. J UOEH [Suppl] 9:123–132 Alfrey AC (1987) Aluminum metabolism and toxicity in uremia. J UOEH [Suppl] 9:123–132
11.
go back to reference Alfrey AC, LeGendre GR, Kaehny WD (1976) The dialysis encephalopathy syndrome. Possible aluminum intoxication. N Engl J Med 294:184–188PubMed Alfrey AC, LeGendre GR, Kaehny WD (1976) The dialysis encephalopathy syndrome. Possible aluminum intoxication. N Engl J Med 294:184–188PubMed
12.
13.
go back to reference Berlyne GM, Yagil R, Ari JB, Weinberger G, Knopf E, Danovitch GM (1972) Aluminum toxicity in rats. Lancet 1:564–568CrossRefPubMed Berlyne GM, Yagil R, Ari JB, Weinberger G, Knopf E, Danovitch GM (1972) Aluminum toxicity in rats. Lancet 1:564–568CrossRefPubMed
14.
go back to reference Cannata-Andia JB, Fernandez-Martin JL (2002) The clinical impact of aluminum overload in renal failure. Nephrol Dial Transplant 17 [Suppl 2]:9–12 Cannata-Andia JB, Fernandez-Martin JL (2002) The clinical impact of aluminum overload in renal failure. Nephrol Dial Transplant 17 [Suppl 2]:9–12
15.
go back to reference Hewitt CD, Savory J, Wills MR (1990) Aspects of aluminum toxicity. Clin Lab Med 10:403–422PubMed Hewitt CD, Savory J, Wills MR (1990) Aspects of aluminum toxicity. Clin Lab Med 10:403–422PubMed
17.
go back to reference Parkinson IS, Ward MK, Feest TG, Fawcett RW, Kerr DN (1979) Fracturing dialysis osteodystrophy and dialysis encephalopathy. An epidemiological survey. Lancet 1:406–409CrossRefPubMed Parkinson IS, Ward MK, Feest TG, Fawcett RW, Kerr DN (1979) Fracturing dialysis osteodystrophy and dialysis encephalopathy. An epidemiological survey. Lancet 1:406–409CrossRefPubMed
18.
go back to reference Sherrard DJ (1974) Letter: the myth of aluminum toxicity. N Engl J Med 290:750 Sherrard DJ (1974) Letter: the myth of aluminum toxicity. N Engl J Med 290:750
19.
go back to reference Ward MK, Feest TG, Ellis HA, Parkinson IS, Kerr DN (1978) Osteomalacic dialysis osteodystrophy: evidence for a water-borne aetiological agent, probably aluminum. Lancet 1:841–845CrossRefPubMed Ward MK, Feest TG, Ellis HA, Parkinson IS, Kerr DN (1978) Osteomalacic dialysis osteodystrophy: evidence for a water-borne aetiological agent, probably aluminum. Lancet 1:841–845CrossRefPubMed
20.
go back to reference Mjoberg B (1989) Aluminum-induced hip fractures: a hypothesis. J Bone Joint Surg Br 71:538PubMed Mjoberg B (1989) Aluminum-induced hip fractures: a hypothesis. J Bone Joint Surg Br 71:538PubMed
21.
go back to reference Mjoberg B, Hellquist E, Mallmin H, Lindh U (1997) Aluminum, Alzheimer’s disease and bone fragility. Acta Orthop Scand 68:511–514PubMed Mjoberg B, Hellquist E, Mallmin H, Lindh U (1997) Aluminum, Alzheimer’s disease and bone fragility. Acta Orthop Scand 68:511–514PubMed
22.
go back to reference Klein GL (1995) Aluminum in parenteral solutions revisited—again. Am J Clin Nutr 61:449–456PubMed Klein GL (1995) Aluminum in parenteral solutions revisited—again. Am J Clin Nutr 61:449–456PubMed
23.
go back to reference Ott SM, Maloney NA, Klein GL, Alfrey AC, Ament ME, Coburn JW, Sherrard DJ (1983) Aluminum is associated with low bone formation in patients receiving chronic parenteral nutrition. Ann Intern Med 98:910–914PubMed Ott SM, Maloney NA, Klein GL, Alfrey AC, Ament ME, Coburn JW, Sherrard DJ (1983) Aluminum is associated with low bone formation in patients receiving chronic parenteral nutrition. Ann Intern Med 98:910–914PubMed
24.
go back to reference Vargas JH, Klein GL, Ament ME, Ott SM, Sherrard DJ, Horst RL, Berquist WE, Alfrey AC, Slatopolsky E, Coburn JW (1988) Metabolic bone disease of total parenteral nutrition: course after changing from casein to amino acids in parenteral solutions with reduced aluminum content. Am J Clin Nutr 48:1070–1078PubMed Vargas JH, Klein GL, Ament ME, Ott SM, Sherrard DJ, Horst RL, Berquist WE, Alfrey AC, Slatopolsky E, Coburn JW (1988) Metabolic bone disease of total parenteral nutrition: course after changing from casein to amino acids in parenteral solutions with reduced aluminum content. Am J Clin Nutr 48:1070–1078PubMed
25.
go back to reference Bush VJ, Moyer TP, Batts KP, Parisi JE (1995) Essential and toxic element concentrations in fresh and formalin-fixed human autopsy tissues. Clin Chem 41:284–294PubMed Bush VJ, Moyer TP, Batts KP, Parisi JE (1995) Essential and toxic element concentrations in fresh and formalin-fixed human autopsy tissues. Clin Chem 41:284–294PubMed
26.
go back to reference Tahán JE, Granadillo VA, Romero RA (1994) Electrothermal atomic absorption spectrometric determination of Al, Cu, Fe, Pb, V and Zn in clinical samples and in certified environmental reference materials. Anal Chim Acta 295:187–197CrossRef Tahán JE, Granadillo VA, Romero RA (1994) Electrothermal atomic absorption spectrometric determination of Al, Cu, Fe, Pb, V and Zn in clinical samples and in certified environmental reference materials. Anal Chim Acta 295:187–197CrossRef
27.
go back to reference Tang S, Parsons PJ, Perl D (1999) Longitudinal and lateral variations in the aluminum concentration of selected caprine, bovine, and human bone samples. Biol Trace Elem Res 68:267–279PubMed Tang S, Parsons PJ, Perl D (1999) Longitudinal and lateral variations in the aluminum concentration of selected caprine, bovine, and human bone samples. Biol Trace Elem Res 68:267–279PubMed
28.
go back to reference Campbell A (2002) The potential role of aluminum in Alzheimer’s disease. Nephrol Dial Transplant 17 [Suppl 2]:17–20 Campbell A (2002) The potential role of aluminum in Alzheimer’s disease. Nephrol Dial Transplant 17 [Suppl 2]:17–20
29.
go back to reference Campbell A, Becaria A, Lahiri DK, Sharman K, Bondy SC (2004) Chronic exposure to aluminum in drinking water increases inflammatory parameters selectively in the brain. J Neurosci Res 75:565–572CrossRefPubMed Campbell A, Becaria A, Lahiri DK, Sharman K, Bondy SC (2004) Chronic exposure to aluminum in drinking water increases inflammatory parameters selectively in the brain. J Neurosci Res 75:565–572CrossRefPubMed
30.
go back to reference Foster HD (2002) Why the preeminent risk factor in sporadic Alzheimer’s disease cannot be genetic. Med Hypotheses 59:57–61CrossRefPubMed Foster HD (2002) Why the preeminent risk factor in sporadic Alzheimer’s disease cannot be genetic. Med Hypotheses 59:57–61CrossRefPubMed
31.
go back to reference Grant WB, Campbell A, Itzhaki RF, Savory J (2002) The significance of environmental factors in the etiology of Alzheimer’s disease. J Alzheimer Dis 4:179–189 Grant WB, Campbell A, Itzhaki RF, Savory J (2002) The significance of environmental factors in the etiology of Alzheimer’s disease. J Alzheimer Dis 4:179–189
32.
go back to reference Matsuzaki S, Manabe T, Katayama T, Nishikawa A, Yanagita T, Okuda H, Yasuda Y, Miyata S, Meshitsuka S, Tohyama M (2004) Metals accelerate production of the aberrant splicing isoform of the presenilin-2. J Neurochem 88:1345–1351PubMed Matsuzaki S, Manabe T, Katayama T, Nishikawa A, Yanagita T, Okuda H, Yasuda Y, Miyata S, Meshitsuka S, Tohyama M (2004) Metals accelerate production of the aberrant splicing isoform of the presenilin-2. J Neurochem 88:1345–1351PubMed
33.
go back to reference Pedersen NL, Gatz M, Berg S, Johansson B (2004) How heritable is Alzheimer’s disease late in life? Findings from Swedish twins. Ann Neurol 55:180–185CrossRefPubMed Pedersen NL, Gatz M, Berg S, Johansson B (2004) How heritable is Alzheimer’s disease late in life? Findings from Swedish twins. Ann Neurol 55:180–185CrossRefPubMed
34.
go back to reference Pedersen NL, Posner SF, Gatz M (2001) Multiple-threshold models for genetic influences on age of onset for Alzheimer disease: findings in Swedish twins. Am J Med Genet 105:724–728CrossRefPubMed Pedersen NL, Posner SF, Gatz M (2001) Multiple-threshold models for genetic influences on age of onset for Alzheimer disease: findings in Swedish twins. Am J Med Genet 105:724–728CrossRefPubMed
35.
go back to reference Buchner DM, Larson EB (1987) Falls and fractures in patients with Alzheimer-type dementia. JAMA 257:1492–1495CrossRefPubMed Buchner DM, Larson EB (1987) Falls and fractures in patients with Alzheimer-type dementia. JAMA 257:1492–1495CrossRefPubMed
36.
go back to reference Gruber-Baldini AL, Zimmerman S, Morrison RS, Grattan LM, Hebel JR, Dolan MM, Hawkes W, Magaziner J (2003) Cognitive impairment in hip fracture patients: timing of detection and longitudinal follow-up. J Am Geriatr Soc 51:1227–1236CrossRefPubMed Gruber-Baldini AL, Zimmerman S, Morrison RS, Grattan LM, Hebel JR, Dolan MM, Hawkes W, Magaziner J (2003) Cognitive impairment in hip fracture patients: timing of detection and longitudinal follow-up. J Am Geriatr Soc 51:1227–1236CrossRefPubMed
37.
go back to reference Walter LC, Lui LY, Eng C, Covinsky KE (2003) Risk of hip fracture in disabled community-living older adults. J Am Geriatr Soc 51:50–55CrossRefPubMed Walter LC, Lui LY, Eng C, Covinsky KE (2003) Risk of hip fracture in disabled community-living older adults. J Am Geriatr Soc 51:50–55CrossRefPubMed
38.
go back to reference Weller I, Schatzker J (2004) Hip fractures and Alzheimer’s disease in elderly institutionalized Canadians. Ann Epidemiol 14:319–324CrossRefPubMed Weller I, Schatzker J (2004) Hip fractures and Alzheimer’s disease in elderly institutionalized Canadians. Ann Epidemiol 14:319–324CrossRefPubMed
39.
go back to reference Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41PubMed Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41PubMed
40.
go back to reference Hellstrom HO, Lindh U, Mjoberg B (2000) Measurement accuracy of aluminum content in bone. Ups J Med Sci 105:67–71PubMed Hellstrom HO, Lindh U, Mjoberg B (2000) Measurement accuracy of aluminum content in bone. Ups J Med Sci 105:67–71PubMed
41.
go back to reference Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359:1761–1767CrossRefPubMed Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359:1761–1767CrossRefPubMed
42.
go back to reference Gomez-Alonso C, Menendez-Rodriguez P, Virgos-Soriano MJ, Fernandez-Martin JL, Fernandez-Coto MT, Cannata-Andia JB (1999) Aluminum-induced osteogenesis in osteopenic rats with normal renal function. Calcif Tissue Int 64:534–541CrossRefPubMed Gomez-Alonso C, Menendez-Rodriguez P, Virgos-Soriano MJ, Fernandez-Martin JL, Fernandez-Coto MT, Cannata-Andia JB (1999) Aluminum-induced osteogenesis in osteopenic rats with normal renal function. Calcif Tissue Int 64:534–541CrossRefPubMed
43.
go back to reference Delmas PD, Recker RR, Chesnut CH 3, Skag A, Stakkestad JA, Emkey R, Gilbride J, Schimmer RC, Christiansen C (2004) Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study. Osteoporos Int 15:792–798CrossRefPubMed Delmas PD, Recker RR, Chesnut CH 3, Skag A, Stakkestad JA, Emkey R, Gilbride J, Schimmer RC, Christiansen C (2004) Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study. Osteoporos Int 15:792–798CrossRefPubMed
44.
go back to reference Quarles LD (1991) Paradoxical toxic and trophic osseous actions of aluminum: potential explanations. Miner Electrolyte Metab 17:233–239PubMed Quarles LD (1991) Paradoxical toxic and trophic osseous actions of aluminum: potential explanations. Miner Electrolyte Metab 17:233–239PubMed
45.
go back to reference Quarles LD, Gitelman HJ, Drezner MK (1989) Aluminum-induced de novo bone formation in the beagle. A parathyroid hormone-dependent event. J Clin Invest 83:1644–1650PubMed Quarles LD, Gitelman HJ, Drezner MK (1989) Aluminum-induced de novo bone formation in the beagle. A parathyroid hormone-dependent event. J Clin Invest 83:1644–1650PubMed
46.
go back to reference Quarles LD, Murphy G, Vogler JB, Drezner MK (1990) Aluminum-induced neo-osteogenesis: a generalized process affecting trabecular networking in the axial skeleton. J Bone Miner Res 5:625–635PubMed Quarles LD, Murphy G, Vogler JB, Drezner MK (1990) Aluminum-induced neo-osteogenesis: a generalized process affecting trabecular networking in the axial skeleton. J Bone Miner Res 5:625–635PubMed
47.
go back to reference Rodriguez M, Felsenfeld AJ, Llach F (1990) Aluminum administration in the rat separately affects the osteoblast and bone mineralization. J Bone Miner Res 5:59–67PubMed Rodriguez M, Felsenfeld AJ, Llach F (1990) Aluminum administration in the rat separately affects the osteoblast and bone mineralization. J Bone Miner Res 5:59–67PubMed
48.
go back to reference Zhu JM, Huffer W, Alfrey AC (1990) Effect of aluminum on bone matrix inductive properties. Kidney Int 38:1141–1145PubMed Zhu JM, Huffer W, Alfrey AC (1990) Effect of aluminum on bone matrix inductive properties. Kidney Int 38:1141–1145PubMed
49.
go back to reference Cumming RG, Klineberg RJ (1994) Aluminum in antacids and cooking pots and the risk of hip fractures in elderly people. Age Ageing 23:468–472PubMed Cumming RG, Klineberg RJ (1994) Aluminum in antacids and cooking pots and the risk of hip fractures in elderly people. Age Ageing 23:468–472PubMed
50.
go back to reference O’Mahony D, Denton J, Templar J, O’Hara M, Day JP, Murphy S, Walsh JB, Coakley D (1995) Bone aluminum content in Alzheimer’s disease. Dementia 6:69–72PubMed O’Mahony D, Denton J, Templar J, O’Hara M, Day JP, Murphy S, Walsh JB, Coakley D (1995) Bone aluminum content in Alzheimer’s disease. Dementia 6:69–72PubMed
51.
go back to reference Ganrot PO (1986) Metabolism and possible health effects of aluminum. Environ Health Perspect 65:363–441PubMed Ganrot PO (1986) Metabolism and possible health effects of aluminum. Environ Health Perspect 65:363–441PubMed
52.
go back to reference D’Haese PC, Couttenye MM, Lamberts LV, Elseviers MM, Goodman WG, Schrooten I, Cabrera WE, De Broe ME (1999) Aluminum, iron, lead, cadmium, copper, zinc, chromium, magnesium, strontium, and calcium content in bone of end-stage renal failure patients. Clin Chem 45:1548–1556PubMed D’Haese PC, Couttenye MM, Lamberts LV, Elseviers MM, Goodman WG, Schrooten I, Cabrera WE, De Broe ME (1999) Aluminum, iron, lead, cadmium, copper, zinc, chromium, magnesium, strontium, and calcium content in bone of end-stage renal failure patients. Clin Chem 45:1548–1556PubMed
53.
go back to reference Navarro JA, Granadillo VA, Salgado O, Rodriguez-Iturbe B, Garcia R, Delling G, Romero RA (1992) Bone metal content in patients with chronic renal failure. Clin Chim Acta 211:133–142CrossRefPubMed Navarro JA, Granadillo VA, Salgado O, Rodriguez-Iturbe B, Garcia R, Delling G, Romero RA (1992) Bone metal content in patients with chronic renal failure. Clin Chim Acta 211:133–142CrossRefPubMed
54.
go back to reference Paakari P, Anker Nielsen A, Lauritsen P, Morkore H, Voipio T, Sigfússon E, Litleskare I, Ericsson O, Nielsen J (2004) Medicines Consumption in the Nordic Countries 1999–2003, http://www.nom-nos.dk/Medicinebook/medicines%20consumption.pdf. Schultz Information, Albertslund, Denmark Paakari P, Anker Nielsen A, Lauritsen P, Morkore H, Voipio T, Sigfússon E, Litleskare I, Ericsson O, Nielsen J (2004) Medicines Consumption in the Nordic Countries 1999–2003, http://​www.​nom-nos.​dk/​Medicinebook/​medicines%20consumption.pdf. Schultz Information, Albertslund, Denmark
55.
go back to reference Pennington JA (1988) Aluminum content of foods and diets. Food Addit Contam 5:161–232PubMed Pennington JA (1988) Aluminum content of foods and diets. Food Addit Contam 5:161–232PubMed
Metadata
Title
The aluminum content of bone increases with age, but is not higher in hip fracture cases with and without dementia compared to controls
Authors
Hans-Olov Hellström
Bengt Mjöberg
Hans Mallmin
Karl Michaëlsson
Publication date
01-12-2005
Publisher
Springer-Verlag
Published in
Osteoporosis International / Issue 12/2005
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-005-1981-6

Other articles of this Issue 12/2005

Osteoporosis International 12/2005 Go to the issue